News
News-Medical.Net on MSN
Closed Loop Medicine launches first personalized GLP-1 dosing platform In U.S.
Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, ...
The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease ...
“Many runners begin to include anaerobic workouts too soon in their training when they would benefit more from focusing on ...
Researchers created a tool to estimate how much different drugs lower blood pressure. It may transform hypertension care by improving treatment selection and saving lives. A newly developed Blood ...
Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.
With sub-$4 corn, fungicide decisions were a bit harder this year, says Erin Marlow. But in the last two to three weeks, disease pressure has increased with identification of southern rust, gray leaf ...
Before a cell divides, its DNA is replicated so that each daughter cell inherits the same genetic information. The two copies ...
Researchers say brain-based therapies like mindfulness and noninvasive stimulation may help ease “latchkey incontinence,” the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results